*
*Hepatoblastoma|109843000
*
*
is
an uncommon malignant liver neoplasm|103356009|363346000|10200004|103356009|363346000|181268008|103356009|372087000|10200004|103356009|372087000|181268008|103356009|21594007|126851005
occurring|272120004
in infants|418119000
and
children|410601007|160499008
and
composed
of tissue|85756007
resembling
fetal
or
mature liver cells|34071009|30396005
or
bile ducts.|28273000

Affecting|247591002|248448006
1
in 1.5 million.|264623001

They
are
usually
present|52101004|246105001
with an abdominal mass.|271860004

The disease|64572001
is
most commonly|4757001
diagnosed|439401001
during a child's first three years|410601007|255216001|421291004|258707000|410601007|232714002|421291004|258707000|160499008|255216001|421291004|258707000|160499008|232714002|421291004|258707000
of life [[1]]|224130005
(http
:
//hepatoblastoma.mditv.com/generalinfo|109843000
)
Alpha-fetoprotein (AFP) commonly|59386002|80152001
is
elevated,|75540009
but
when
AFP|59386002|80152001
is
not
elevated|75540009
at diagnosis|439401001
the prognosis|20481000
is
poor.[1]|11403006|255351007

Hepatoblastomas|109843000
originate
from immature liver precursor cells,|1090009|10200004|418318001|1090009|181268008|418318001
usually unifocal|261034003
and
affect|4065008
the right lobe|24028007
of the liver more often|10200004|70232002|181268008|70232002
than the left lobe,|7771000
can
metastasize.

Patients|116154003
with familial adenomatous polyposis|72900001
(FAP,
a syndrome
of early-onset colonic polyps|264499004|77374008|68496003
and
adenocarcinoma,|443961001
frequently|70232002
develop
hepatoblastomas.|109843000

Also beta-catenin mutations|52095000|55446002|260989008|55446002
have
been
shown
to
be
common|72906007
in sporadic hepatoblastomas,|75741005|109843000
occurring|272120004
in
as
many
as 67%
of patients.[4][5]|116154003

Recently|6493001
on other components|74964007|246093002
of the Wnt signaling pathway|38952000
have
also
demonstrated
a likely role|2931005
for constitutive activation
of this pathway
in the etiology|134198009
of hepatoblastoma.[5][6]|109843000

Accumulating evidence|18669006
suggests
that hepatoblastoma|109843000
is
derived
from a pluripotent stem cell.[7]|418318001|419758009

One study|421379005|110465008|421379005|224699009
suggests
that low birth weight|276610007
might
be
a risk factor|80943009
for hepatoblastoma.[8]|109843000

A Children's Cancer Group study byt Buckley|410601007|363346000|261586004|110465008|410601007|363346000|261586004|224699009|410601007|363346000|160481000|110465008|410601007|363346000|160481000|224699009|410601007|363346000|389109008|110465008|410601007|363346000|389109008|224699009|410601007|372087000|261586004|110465008|410601007|372087000|261586004|224699009|410601007|372087000|160481000|110465008|410601007|372087000|160481000|224699009|410601007|372087000|389109008|110465008|410601007|372087000|389109008|224699009|160499008|363346000|261586004|110465008|160499008|363346000|261586004|224699009|160499008|363346000|160481000|110465008|160499008|363346000|160481000|224699009|160499008|363346000|389109008|110465008|160499008|363346000|389109008|224699009|160499008|372087000|261586004|110465008|160499008|372087000|261586004|224699009|160499008|372087000|160481000|110465008|160499008|372087000|160481000|224699009|160499008|372087000|389109008|110465008|160499008|372087000|389109008|224699009
et
al
(1989
)
found|404684003
significant linkage|386134007
between hepatoblastoma|109843000
and
maternal|72705000
and
paternal exposure|224944003|71677004|224944003|24932003
to metals.|425620007

The most common method|4757001|72906007|260686004|4757001|72906007|272394005
of testing|272393004
for hepatoblastoma|109843000
is
to a blood test|252275004
checking|360160009
the Alpha-fetoprotein.|59386002|80152001

Alpha-fetoprotein (AFP)|59386002|80152001
is
used|394850002
as a biomarker to
help
determine
the presence|386397008
of liver cancer|93870000
in children.|410601007|160499008

At birth,|3950001
infants|418119000
have
relatively high levels|75540009|258395000|371879000|258395000
of AFP,
which
fall|1912002
to normal adult levels|17621005|133936004|258395000|258744000|133936004|258395000
by the first year|255216001|258707000|255216001|259039008|232714002|258707000|232714002|259039008
of life.|224130005

The Normal levels|17621005|258395000|258744000|258395000
for AFP
in children|410601007|160499008
has
been
reported|229059009|223458004
as lower|261122009
than 50 nanograms per milliliter (ng / ml)|258806002
and
10 ng/ml.|258806002

AFP Blood Test AFP
greater|263768009
than 500
(ng/ml|259035002
)
is
a significant indicator|386134007
of hepatoblastoma.|109843000

AFP
is
also
used|394850002
as an indicator
of the success|385669000
of treatments.|276239002

If treatments|276239002
are
successful|385669000
in removing|127485006
the cancer|363346000|372087000
it
can
be
expected
that AFP levels|258395000
will
fall|1912002
back
to normal.[9]|17621005|258744000

Surgical resection,|118292001|128303001
adjuvant chemotherapy|427067006|416608005|427067006|367336001
prior to resection,|118292001|128303001
and
liver transplantation|18027006
have
been
used|394850002
to
treat|395077000
these neoplasms,|108369006
[10][11] primary transplantation|63161005|263903005|261424001|263903005
provides
high, long term, disease-free survival rate|75540009|64572001|37837009|371879000|64572001|37837009
in the range
of 80%,
in cases|398241000|413769002
of complete resection|255594003|118292001|255594003|128303001
and
adjuvant chemotherapy survival rates|427067006|416608005|427067006|367336001
approach
100%.

The presence|386397008
of metastases|128462008
is
the most potent predictor|4757001|30207005
of poor prognosis.[14]|170969009

M
:
MUS,|223541006|447482001
DF+DRCT

anat (h/n,|89177007|258322007|286551008
u,
t/d,
a/p,
l/phys/devp/hist|258995007|420559008

noco
(m,|258311008
s,|288495006
c/cong
(d/tumr,|876000
sysi/epon,
injr

proc,
drug|410942007
(M1A/3|261927002

M
:
DIG

anat(t,
g,|258795003
p/phys/devp/enzy|20304007

noco/cong/tumr,
sysi/epon

proc,
drug|410942007
(A2A/2B/3/4/5/6/7/14/16,|264663000
blte

